Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;97(7):647-655.
doi: 10.1111/imcb.12278. Epub 2019 Jun 23.

Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection

Affiliations
Review

Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection

Pia Steigler et al. Immunol Cell Biol. 2019 Aug.

Abstract

Tuberculosis (TB) is a serious infectious disease caused by infection with Mycobacterium tuberculosis, and kills more people annually than any other single infectious agent. Although a vaccine is available, it is only moderately effective and an improved vaccine is urgently needed. The ability to develop a more effective vaccine has been thwarted by a lack of understanding of the mechanism of vaccine-induced immune protection. Over recent decades, many novel TB vaccines have been developed and almost all have aimed to generate memory CD4 T cells. In this review, we critically evaluate evidence in the literature that supports the contention that memory CD4 T cells are the prime mediators of vaccine-induced protection against TB. Because of the lack of robust evidence supporting memory CD4 T cells in this role, the potential for B-cell antibody and "trained" innate cells as alternative mediators of protective immunity is explored.

Keywords: B-cell memory; BCG; memory T cells; trained immunity; tuberculosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kirman JR, Henao-Tamayo MI, Agger EM. The memory immune response to tuberculosis. Microbiol Spectr 2016; 4. https://doi.org/10.1128/microbiolspec.TBTB2-0009-2016
    1. Rodrigues LC, Pereira SM, Cunha SS, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005; 366: 1290-1295.
    1. WHO. BCG vaccines: WHO position paper - February 2018. WHO Wkly Epidemiol Rec 2018; 93: 73-96.
    1. Mangtani P, Abubakar I, Ariti C, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58: 470-480.
    1. Mangtani P, Nguipdop-Djomo P, Keogh RH, et al. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study. Int J Epidemiol 2018; 47: 193-201.

Publication types

MeSH terms